MR evaluation of rectal cancer: Current concepts

Current Problems in Diagnostic Radiology

Volumn 42, Issue 3, 2013, Pages 99-112

  Beaumont, Claire ^a   Pandey, Tarun ^a   Gaines Fricke, R ^a   Laryea, Jonathan ^a   Jambhekar, Kedar ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

CANCER CHEMOTHERAPY; CANCER MORPHOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CIRCUMFERENTIAL RESECTION MARGIN; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FASCIA; HUMAN; INTESTINE DISTENSION; LYMPH NODE METASTASIS; MESORECTAL FASCIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGICAL PARAMETERS; PATHOLOGICAL ANATOMY; PREOPERATIVE EVALUATION; RECTUM CANCER; RECTUM CARCINOMA; RECTUM RESECTION; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; RECTUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84878128307     PISSN: 03630188     EISSN: 15356302     Source Type: Journal    
DOI: 10.1067/j.cpradiol.2012.08.002     Document Type: Review

References (50)

1. MERCURY Study Group Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Bmj 2006, 333:779.
2. American Cancer Society Colorectal Cancer Facts and Figures 2011-2013 2011, American Cancer Society, Atlanta.
3. Kaur H., Choi H., You Y.N., et al. MR Imaging for preoperative evaluation of primary rectal cancer: practical considerations. Radiographics 2012, 32:389-409.
4. Torkzad M.R., Påhlman L., Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging 2010, 1:245-267.
5. Klessen C., Rogalla P., Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol 2006, 17:379-389.
6. Beets-Tan R.G.H., Beets G.L. Rectal cancer: review with emphasis on MR imaging. Radiology 2004, 232:335-346.
7. Sobin L.H., Gospodarowicz M.K., Wittekind C.H. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours 2010, John Wiley & Sons Ltd., Oxford.
8. Merkel S., Mansmann U., Siassi M. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001, 16:298-304.
9. Frasson M., Garcia-Granero E., Roda D., et al. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer 2011, 117:3118-3125.
10. Beets-Tan R.G., Beets G.L., Bliegen R.F., et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001, 356:497-504.
11. Taylor F.G.M., Quirke P., Heald R.J., et al. One millimeter is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg 2011, 98:872-879.
12. Park I.J., Kim J.C. Adequate length of the distal resection margin in rectal cancer: from the oncological point of view. J Gastrointest Surg 2010, 14:1331-1337.
13. Bujko K., Rutkowski A., Chang G., et al. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol 2012, 19:801-808.
14. Hodgman C.G., MacCarty R.L., Wolff B.G., et al. Preoperative staging of rectal carcinoma by computed tomography and 0.15T magnetic resonance imaging: preliminary report. Dis Colon Rectum 1986, 29:446-450.
15. Vogl T.J., Pegios W., Mack M.G., et al. Accuracy of staging rectal tumors with contrast-enhanced transrectal MR imaging. Am J Roentgenol 1997, 168:1427-1434.
16. DeLange E.E., Fechner R.E., Edge S.B., et al. Preoperative staging of rectal carcinoma with MR imaging: surgical and histopathological correlation. Radiology 1990, 176:623-628.
17. Slater A., Halligan S., Taylor S.A., et al. Distance between the rectal wall and mesorectal fascia measured by MRI: effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol 2006, 61:65-70.
18. Kim H., Lim J.S., Choi J.Y., et al. Rectal cancer: comparison of accuracy of local-regional staging with two- and three-dimensional preoperative 3-T MR imaging. Radiology 2010, 254:485-492.
19. Okizuka H., Sugimura K., Yoshizako T., et al. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging. J Magn Reson Imaging 1996, 6:465-471.
20. Maier A.G., Kersting-Sommerhoff B., Reeders J.W., et al. Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristine and IV gadodiamide injection: results of a multicenter phase II trial. J Magn Reson Imaging 2000, 12:651-660.
21. Vliegen R.F.A., Beets G.L., von Meyenfeldt M.F., et al. Rectal cancer: MR imaging in local staging-isgadolinium-based contrast material helpful?. Radiology 2005, 234:179-188.
22. Kim Seung H., Lee J.M., Hong S.H., et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo and radiation therapy. Radiology 2009, 253:116-125.
23. Lambregts D.M., Vandecaveye V., Barbaro B., et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011, 18:2224-2231.
24. Curvo-Semedo L., Lambregts D.M., Maas M., et al. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging 2012, 35:1365-1371.
25. Rudisch A., Kremser C., Judmaier W., et al. Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. Eur J Radiol 2005, 53:514-519.
26. Koh D.M., Brown G., Temple L., et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology 2004, 231:91-99.
27. Brown G., Richards C.J., Bourne M.W., et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003, 227:371-377.
28. Garcia-Aguilar J., Pollack J., Lee S., et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002, 45:10-15.
29. Halefoglu A.M., Yildirim S., Avlanmis O., et al. Endorectal ultrasonography versus phased-array magnetic resonance imaging for preoperative staging of rectal cancer. World J Gastroenterol 2008, 14:3504-3510.
30. Puli S.R., Bechtold M.L., Reddy J.B.K., et al. How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review. Ann Surg Oncol 2009, 16:254-265.
31. Harewood G.C. Assessment of publication bias in the reporting of EUS performance in staging rectal cancer. Am J Gastroenterol 2005, 100:808-816.
32. Bipat S., Glas A.S., Slors F.J.M., et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-ameta-analysis. Radiology 2004, 232:773-783.
33. Fernandez-Esparrach G., Ayuso-Colella J.R., Sendino O., et al. EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study. Clin Endosc 2011, 74:347-354.
34. Kim J.C., Kim H.C., Yu C.S., et al. Efficacy of 3-dimensional endorectal ultrasonography compared with conventional ultrasonography and computed tomography in preoperative rectal cancer staging. Am J Surg 2006, 192:89-97.
35. Mackay S.G., Pager C.K., Joseph D., et al. Assessment of the accuracy of transrectal ultrasonography in anorectal neoplasia. Br J Surg 2003, 90:346-350.
36. Manger T., Stroh C. Accuracy of endorectal ultrasonography in the preoperative staging of rectal cancer. Tech Coloproctol 2004, 1(suppl 8):14-15.
37. Marusch F., Koch A., Schmidt U., et al. Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy 2002, 34:385-390.
38. Akasu T., Iinuma G., Takawa M., et al. Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer. Ann Surg Oncol 2009, 16:2787-2794.
39. Branagan G., Chave H., Fuler C., et al. Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer?. Dis Colon Rectum 2004, 47:1317-1322.
40. Burton S., Brown G., Daniels I., et al. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2006, 65:445-451.
41. Chiesura-Corona M., Muzzio P.C., Giust G., et al. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging 2001, 26:134-138.
42. MERCURY Study Group Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007, 243:132-139.
43. Kim Y.W., Cha S.W., Pyo J., et al. Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study. World J Surg 2009, 33:1952-1960.
44. Kwak J.Y., Kim J.S., Kim H.J., et al. Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer. World J Surg 2012, 36:1898-1905.
45. Kwok H., Bissett I.P., Hill G.L. Preoperative staging of rectal cancer. Int J Colorectal Dis 2000, 15:9-20.
46. Tateishi U., Maeda T., Morimoto T., et al. Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer. Eur J Nucl Med Mol Imaging 2007, 34:1627-1634.
47. Abdel-Nabi H., Doerr R., Lamonica D., et al. Staging of primary colorectal carcinomas with fluorine-18 flourodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998, 206:755-760.
48. Vliegen R.F.A., Beets G.L., Lammering G., et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008, 246:454-462.
49. Park M.J., Kim S.H., Lee S.J., et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology 2011, 260:771-780.
50. Gollub M.J., Gultekin D.H., Akin O., et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol 2012, 22:821-831.